Albert David Limited has informed the Exchange about Credit Rating- Revision

Rating watch negativeNew credit facilityCredit & Debt View source PDF Explain this filing

ALBERTDAVD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.9%Reaction day

₹837.65

prior close

₹841.75

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+0.6% vs market

Pharmaceuticals peers, median of 148sector+0.5%+0.4% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 0.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

+0.1

15m

-0.3

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.9+0.3+0.6+0.5+0.4

Next day

-0.3+0.6-0.9+0.4-0.7

+0.1+1.0-1.0+1.2-1.1

+1.6+3.0-1.4+1.9-0.3

+0.6+3.0-2.4+1.8-1.2

+0.8+3.5-2.8+2.2-1.5

+5.1+4.5+0.6+2.8+2.3

15d

+7.8+4.6+3.2+3.5+4.3

+9.4+6.0+3.3+5.6+3.8

-2.7+2.3-5.0+0.2-2.9

-4.0+3.9-7.9+1.8-5.8

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 148Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

CARE Ratings has revised the outlook on Albert David's bank facilities from Stable to Negative, while reaffirming the actual ratings. Long Term Bank Facilities of Rs. 51.50 crore (enhanced from Rs. 10.50 crore) retain the CARE A rating, and Long Term/Short Term Bank Facilities of Rs. 13.00 crore (enhanced from Rs. 8.00 crore) hold CARE A/CARE A1. The total rated bank facilities now stand at Rs. 64.50 crore. The Negative outlook suggests CARE sees potential downside risk to the rating over the next 12 months, likely tied to concerns about the company's FY25 operational and financial performance. The company has not disclosed the specific concerns from CARE that triggered the outlook change.

Likely market impact

The rating itself is unchanged, so the company's borrowing costs shouldn't shift immediately, but the Negative outlook is a warning that the rating could be downgraded if conditions worsen. Shareholders should watch for the detailed CARE report for the specific reasons behind the outlook revision, as this could weigh on the stock sentiment.